Veracyte | VCYT - Fremdkapital





Fremdkapital Veränderung Datum
Agenus USD 169.66M 146.06M 2025-12
Agilent USD 3.05B 1000K 2026-03
Arrowhead Research USD 1.23B 687.3M 2026-03
Bruker USD 1.66B 189.6M 2026-03
Heron Therapeutics USD 140.64M 975K 2025-12
Illumina USD 1.49B 0 2026-03
Intrexon USD 0 198.67M 2024-06
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
Laboratory Of America USD 5.9B 748.3M 2026-03
Ligand Pharmaceuticals USD 446.19M 702K 2025-12
Myriad Genetics USD 120.3M 400K 2026-03
Rigel Pharmaceuticals USD 0 0 2024-09
Roche Holding CHF 25.22B 2.21B 2026-06
Sangamo BioSciences USD 0 0 2022-06
Siemens EUR 41.52B 1.31B 2026-03
Sonic Healthcare AUD 4.19B 333.39M 2024-12
Thermo Fisher Scientific USD 39.18B 890M 2026-06
Veracyte USD 0 0 2025-03
Waters USD 5.22B 3.81B 2026-03